Estimated Annual Spending on Aducanumab in the US Medicare Program

被引：14

作者：

Mafi, John N. ^{[1
,2
,3
]}

Leng, Mei ^{[2
]}

Arbanas, Julia Cave ^{[2
]}

Tseng, Chi-Hong ^{[2
]}

Damberg, Cheryl L. ^{[3
]}

Sarkisian, Catherine ^{[2
,4
]}

Landon, Bruce E. ^{[5
,6
]}

机构：

[1] UCLA, David Geffen Sch Med, Dept Med, Div Gen Med & Hlth Serv Res, 1100 Glendon Ave 908, Los Angeles, CA 90024 USA

[2] UCLA, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA

[3] RAND Corp, Santa Monica, CA USA

[4] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA

[5] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02115 USA

[6] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA

来源：

JAMA HEALTH FORUM | 2022年 / 3卷 / 01期

关键词：

D O I：

10.1001/jamahealthforum.2021.4495

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

This cross-sectional study examines upper bound and lower bound annualized Medicare costs for administering aducanumab to beneficiaries with the approved indications of mild cognitive impairment or mild dementia.

引用

页数：5

共 50 条

[1] ESTIMATED ANNUAL SPENDING ON LECANEMAB IN THE US MEDICARE PROGRAM
Arbanas, Julia C.
Damberg, Cheryl
Leng, Mei
Harawa, Nina
Sarkisian, Catherine
Landon, Bruce E.
Mafi, John N.
JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S268 - S269
[2] Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program
Arbanas, Julia Cave
Damberg, Cheryl L.
Leng, Mei
Harawa, Nina
Sarkisian, Catherine A.
Landon, Bruce E.
Mafi, John N.
JAMA INTERNAL MEDICINE, 2023, 183 (08) : 885 - 889
[3] Estimate annual spending on aducanumab in the US Medicare program (vol 3, e214495, 2022)
Mafi, J. N.
Leng, M.
Arbanas, J. C.
JAMA HEALTH FORUM, 2022, 3 (02):
[4] Estimated wasteful spending on aducanumab dispensing in the US Medicare population: A cross-sectional analysis
Oronce, Carlos Irwin A.
Arbanas, Julia Cave
Leng, Mei
Landon, Bruce E.
Damberg, Cheryl L.
Sarkisian, Catherine
Mafi, John N.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (09) : 2714 - 2718
[5] Reducing Wasteful Spending on Discarded Lecanemab in the US Medicare Program
Zhou, Frank F.
Tseng, Chi-Hong
Leng, Mei
Delarmente, Benjo A.
Damberg, Cheryl L.
Sarkisian, Catherine A.
Mafi, John N.
JAMA INTERNAL MEDICINE, 2024, 184 (12) : 1477 - 1479
[6] US Healthcare Annual Spending Estimated to Rise by 5.8% on Average Through 2024
Morgan, Laura
AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (05): : 272 - 272
[7] Cost implications of patient spending on heart failure medications in the US Medicare program
McGee, Blake Tyler
Parikh, Rishika
Phillips, Victoria
JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2021, 12 (02) : 101 - 108
[8] What does Medicare spending buy us?
Cutler, DM
MEDICARE REFORM: ISSUES AND ANSWERS, 1999, 1 : 131 - 152
[9] US health spending up; medicare expanded
Catton, M
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (12) : 1545 - 1545
[10] Medicare Spending after 3 Years of the Medicare Shared Savings Program
McWilliams, J. Michael
Hatfield, Laura A.
Landon, Bruce E.
Hamed, Pasha
Chernew, Michael E.
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (12): : 1139 - 1149

← 1 2 3 4 5 →